Literature DB >> 10686145

Replication-associated activities of purified human papillomavirus type 11 E1 helicase.

W J Rocque1, D J Porter, J A Barnes, E P Dixon, D C Lobe, J L Su, D H Willard, R Gaillard, J P Condreay, W C Clay, C R Hoffman, L K Overton, G Pahel, T A Kost, W C Phelps.   

Abstract

Replication of human papillomavirus type11 (HPV11) requires both the E1 and the E2 proteins. E1 is structurally and functionally similar to SV40 large T-antigen and is a DNA helicase/NTPase that binds to the origin of replication and initiates viral DNA replication. The biochemical characterization of HPV E1 is incompletely documented in the literature in part because of difficulties in expressing and purifying the protein. Herein, we report a method for the overexpression of full-length, untagged E1 (73.5 kDa) in baculovirus-infected Trichoplusia ni insect cells and the purification to homogeneity using a two-step procedure. The purified protein is a nonspecific NTPase that hydrolyzes ATP, dATP, UTP, or GTP equally well. Point mutations were made in the putative NTPase domain to verify that the activities observed were encoded by E1. Purified mutant D523N had negligible ATPase and helicase activities but retained DNA-binding activity. Sedimentation equilibrium ultracentrifugation and glycerol gradient centrifugation demonstrated that the wild-type protein is primarily a hexamer in its purified form. Secondary structure determination by circular dichroism revealed a large percentage of alpha-helical structure consistent with secondary structure predictions. These data define a fundamental set of biochemical and kinetic parameters for HPV E1 which are a critical prerequisite to future mechanistic studies of the enzyme. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686145     DOI: 10.1006/prep.1999.1182

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  11 in total

1.  The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.

Authors:  Eric A Abbate; James M Berger; Michael R Botchan
Journal:  Genes Dev       Date:  2004-08-02       Impact factor: 11.361

2.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 3.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

4.  The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome.

Authors:  Nagayasu Egawa; Tomomi Nakahara; Shin-Ichi Ohno; Mako Narisawa-Saito; Takashi Yugawa; Masatoshi Fujita; Kenji Yamato; Yukikazu Natori; Tohru Kiyono
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

5.  Human TATA binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing E1-E2 protein complex formation on the viral origin of replication.

Authors:  Kelly A Hartley; Kenneth A Alexander
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Biochemical and genetic analysis of the vaccinia virus d5 protein: Multimerization-dependent ATPase activity is required to support viral DNA replication.

Authors:  Kathleen A Boyle; Lisa Arps; Paula Traktman
Journal:  J Virol       Date:  2006-11-08       Impact factor: 5.103

Review 7.  Targeting human papillomavirus genome replication for antiviral drug discovery.

Authors:  Jacques Archambault; Thomas Melendy
Journal:  Antivir Ther       Date:  2013-04-24

8.  Characterization of the minimal DNA binding domain of the human papillomavirus e1 helicase: fluorescence anisotropy studies and characterization of a dimerization-defective mutant protein.

Authors:  S Titolo; K Brault; J Majewski; P W White; J Archambault
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 9.  Recent advances in the search for antiviral agents against human papillomaviruses.

Authors:  Amélie Fradet-Turcotte; Jacques Archambault
Journal:  Antivir Ther       Date:  2007

Review 10.  Papillomavirus E1 proteins: form, function, and features.

Authors:  Van G Wilson; Michael West; Kelly Woytek; Dandapani Rangasamy
Journal:  Virus Genes       Date:  2002-06       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.